The Global Health Body Issues Warning Over Severe Scarcity of Obesity Jabs
Fewer than a tenth of people that would benefit from obesity jabs including Wegovy are able to get them, states the global health agency as it publishes its inaugural advice on the medications.
Considering in excess of 1,000,000,000 people worldwide now living with obesity, it is urging increased and just access to these injectable treatments.
Based on estimates, more than two billion could be obese by 2030 without intervention.
"Our latest guidelines recognises that excess weight is a long-term condition that can be treated with thorough and lifelong support," said WHO director-general Tedros Adhanom Ghebreyesus.
High costs, insufficient output, and supply-chain constraints are significant hurdles to universal availability to the treatments that can help people shift considerable weight, says the organization.
Weight-Loss Drug Scarcity
Even in the current most favorable case, the supply of these medications could only cover approximately 100 million people β fewer than 10% of the global need, per the WHO.
The recommendation calls on countries and companies to expand access, through strategies like patent sharing.
The intellectual property rights on the active ingredient β the primary component of a leading brand β is due to expire in multiple nations in 2026.
How Weight-Loss Injections Operate
The injections replicate a natural hormone to reduce digestion speed, suppress the appetite and enhance the sense of being full so people consume fewer calories.
Individuals commonly see weight reduction within a few weeks of starting on the once-weekly jabs.
Evidence indicates users may regain a significant portion after a year of halting the drug, when their typical appetite return.
Being carrying excess weight raises your chance for contracting health problems, including diabetes, heart disease, stroke, and some malignancies.
Obesity impacts individuals in all nations and was linked to over three and a half million deaths worldwide in 2024, per the health agency.